Hikma Pharmaceuticals clinical trials

The registry lists 118 studies whose lead sponsor is Hikma Pharmaceuticals or one of 2 companies grouped under it. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 118. Browse all 118 →

• Pharmacokinetics and Safety of a Single Dose of Epinephrine Nasal Spray in Paediatric Allergy PatientsNot yet recruitingNCT07891780Phase 2

  Sponsor listed in the registry: Hikma Pharmaceuticals USA Inc.

• Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid LeukemiaRecruitingNCT05282108

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IVRecruitingNCT02323399Phase 4

  Sponsor listed in the registry: West-Ward Pharmaceutical · West-Ward Pharmaceutical — acquired company within the Hikma Pharmaceuticals group

• Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) PatientsActive, not recruitingNCT06572982Not applicable

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)CompletedNCT06326697Phase 1

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in EgyptCompletedNCT05423769

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA RegionCompletedNCT04468165

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With SchizophreniaCompletedNCT05563818

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaCompletedNCT03625388Phase 2

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia PatientsCompletedNCT03452501

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in EgyptCompletedNCT03454503

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.TerminatedNCT03460678Phase 4

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in JordanCompletedNCT03348046

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)CompletedNCT03535870Not applicable

  Sponsor listed in the registry: West-Ward Pharmaceutical · West-Ward Pharmaceutical — acquired company within the Hikma Pharmaceuticals group

• Study of Oral Morphine Sulfate Administration in Pediatric SubjectsCompletedNCT03429400Phase 3

  Sponsor listed in the registry: West-Ward Pharmaceutical · West-Ward Pharmaceutical — acquired company within the Hikma Pharmaceuticals group

• A Study of Oral Codeine Sulfate in Pediatric Patients With Post-procedural PainTerminatedNCT01676493Phase 3

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in JordanCompletedNCT03517982

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Efficacy and Safety of a Generic Rosuvastatin in a Real-world SettingCompletedNCT03516955

  Sponsor listed in the registry: Hikma Pharmaceuticals LLC

• Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric SubjectsCompletedNCT01322360Phase 4

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted ConditionsCompletedNCT01107353Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting ConditionsCompletedNCT00602173Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting ConditionsCompletedNCT00601874Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting ConditionsCompletedNCT00826865Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed ConditionsCompletedNCT01102465Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Levetiracetam 1g Tablets Under Fed ConditionsCompletedNCT00827320Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Anastrozole 1 mg Under Fed ConditionsCompletedNCT01155089Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted ConditionsCompletedNCT01659931Early Phase 1

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting ConditionsCompletedNCT01132729Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting ConditionsCompletedNCT00702091Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Zidovudine Under Fed ConditionsCompletedNCT00601562Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Protriptyline 10 mg Tablets Under Fasted ConditionsCompletedNCT00754962Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fed ConditionsCompletedNCT01570894Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Ramipril 10 mg Capsules Under Fed ConditionsCompletedNCT00702260Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of 300 mg Lithium Carbonate Under Fed ConditionsCompletedNCT00602394Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Zolpidem Tartrate Under Fasting ConditionsCompletedNCT00601666Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed ConditionsCompletedNCT01712126Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed ConditionsCompletedNCT01367626Phase 1

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Zidovudine Under Fasting ConditionsCompletedNCT00602550Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed ConditionsCompletedNCT01659892Early Phase 1

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed ConditionsCompletedNCT01703468Phase 1

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed ConditionsCompletedNCT01591889Phase 1

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Food Effect Study of Codeine SulfateCompletedNCT01009892Phase 1

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted ConditionsCompletedNCT01161667Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Dose Proportionality and Food Effect of Morphine SulfateCompletedNCT00994539Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted ConditionsCompletedNCT01903122Early Phase 1

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Levetiracetam 1g Under Fasted ConditionsCompletedNCT00826722Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fed ConditionsCompletedNCT00893958Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Meloxicam Tablets Under Fasting ConditionsCompletedNCT00618163Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed ConditionsCompletedNCT00616863Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals

• Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed ConditionsCompletedNCT01132716Not applicable

  Sponsor listed in the registry: Roxane Laboratories · First submitted before Roxane Laboratories became part of Hikma Pharmaceuticals